Natixis Advisors Portfolio holdings
AUM
$63B
1-Year Return
23.95%
This Quarter Return
+2.91%
1 Year Return
+23.95%
3 Year Return
+105.73%
5 Year Return
+183.26%
10 Year Return
+413.93%
AUM
$53.5B
AUM Growth
+$2.24B
(+4.4%)
Cap. Flow
+$1.84B
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
23.62%
Holding
1,680
New
114
Increased
890
Reduced
598
Closed
75
Top Buys
| 1 |
Vanguard Growth ETF
VUG
|
$164M |
| 2 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$146M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$141M |
| 4 |
Apple
AAPL
|
$136M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
$107M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$77.2M |
| 2 |
Netflix
NFLX
|
$53.5M |
| 3 |
Tesla
TSLA
|
$49.2M |
| 4 |
Zoetis
ZTS
|
$43.2M |
| 5 |
Antero Resources
AR
|
$38.8M |
Sector Composition
| 1 | Technology | 25.43% |
| 2 | Financials | 14.36% |
| 3 | Consumer Discretionary | 10.74% |
| 4 | Healthcare | 10% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Moderna
MRNA
$9.78B
| $433K | ﹤0.01% |
10,405
-1,169
| -10% | -$48.6K |
|
1502
Origin Bancorp
OBK
$1.21B
| $432K | ﹤0.01% |
12,982
+1,958
| +18% | +$65.2K |
|
1503
Olin
OLN
$2.9B
| $431K | ﹤0.01% |
+12,755
| New | +$431K |
|
1504
Teradata
TDC
$1.99B
| $427K | ﹤0.01% |
13,719
-80
| -0.6% | -$2.49K |
|
1505
Select Water Solutions
WTTR
$881M
| $426K | ﹤0.01% |
32,188
-315
| -1% | -$4.17K |
|
1506
Alamos Gold
AGI
$13.5B
| $423K | ﹤0.01% |
22,966
-4,715
| -17% | -$86.8K |
|
1507
Vital Energy
VTLE
$635M
| $422K | ﹤0.01% |
13,649
+1,185
| +10% | +$36.6K |
|
1508
Match Group
MTCH
$9.18B
| $421K | ﹤0.01% |
12,873
-523
| -4% | -$17.1K |
|
1509
Avanos Medical
AVNS
$590M
| $413K | ﹤0.01% |
25,944
+4,492
| +21% | +$71.5K |
|
1510
Blackstone Secured Lending
BXSL
$6.72B
| $412K | ﹤0.01% |
12,758
-2,725
| -18% | -$88K |
|
1511
Iridium Communications
IRDM
$2.67B
| $412K | ﹤0.01% |
14,204
-1,286
| -8% | -$37.3K |
|
1512
PagerDuty
PD
$1.54B
| $412K | ﹤0.01% |
22,539
-15,868
| -41% | -$290K |
|
1513
Nuveen ESG Mid-Cap Value ETF
NUMV
$400M
| $411K | ﹤0.01% |
11,808
+1,274
| +12% | +$44.3K |
|
1514
Banco de Chile
BCH
$15.4B
| $410K | ﹤0.01% |
18,062
-91
| -0.5% | -$2.07K |
|
1515
Spyre Therapeutics
SYRE
$1.03B
| $403K | ﹤0.01% |
+17,300
| New | +$403K |
|
1516
Virtu Financial
VIRT
$3.29B
| $401K | ﹤0.01% |
+11,243
| New | +$401K |
|
1517
Northwest Natural Holdings
NWN
$1.71B
| $398K | ﹤0.01% |
+10,069
| New | +$398K |
|
1518
iShares Global REIT ETF
REET
$4B
| $395K | ﹤0.01% |
+16,479
| New | +$395K |
|
1519
Avidity Biosciences
RNA
$6.48B
| $395K | ﹤0.01% |
+13,577
| New | +$395K |
|
1520
Structure Therapeutics
GPCR
$1.27B
| $392K | ﹤0.01% |
14,459
-12,216
| -46% | -$331K |
|
1521
Progyny
PGNY
$1.94B
| $390K | ﹤0.01% |
22,581
-5,802
| -20% | -$100K |
|
1522
Cadre Holdings
CDRE
$1.3B
| $389K | ﹤0.01% |
+12,058
| New | +$389K |
|
1523
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$722M
| $384K | ﹤0.01% |
10,720
+13
| +0.1% | +$466 |
|
1524
First Advantage
FA
$2.79B
| $381K | ﹤0.01% |
20,353
+5,317
| +35% | +$99.5K |
|
|
NVEE
1525
DELISTED
NV5 Global
NVEE
| $377K | ﹤0.01% |
+19,994
| New | +$377K |
|